Ekaterina Vert-Wong (Nostopharma)

Resourceful and Scrappy Just Might Win the Race for a Biobased Economy

INNOVATIONS

OF THE WORLD

FOR TODAY'S BIG THINKERS
Maryland 3D Cover Right

As Featured In:

INNOVATE® Maryland

Maryland 3D Cover Right

As Featured In:

INNOVATE® Maryland

Across roles at the intersection of innovation, sustainability, and human impact, Ekateirna Vert-Wong has demonstrated a belief that progress is most meaningful when it benefits people while safeguarding the future. Both as an executive leading biomedical teams and an entrepreneur building climate-resilient medicine in Maryland, her path has been guided by curiosity, resourcefulness, and the belief that even unlikely beginnings can lead to meaningful impact.

From the Mountains to Maryland

Ekaterina’s journey began far from the institutions where she works today. She grew up among the Ural and Altai Mountains, where the natural world shaped her perspective. “My grandfather – a WWII veteran who returned to his village severely wounded and was healed by local natural medicine – inspired my fascination with healing and biological resilience,” she says.

Awarded the 1997 Muskie Graduate Fellowship – the only recipient from the Eastern USSR – she chose Dartmouth College, studying at Thayer and Tuck. Today, she is giving back in STEM education by serving as a mentor to robotics teams and science competitions. “I want new generations to continue excelling in math and the sciences because our world needs more people committed to sustainable technology and engineering of resilient systems,” she says.

Her philosophy is captured in a quote she often shares with her three children, by tennis legend Arthur Ashe: “Start where you are. Use what you have. Do what you can.”

“It’s a reminder,” she adds, “that even the most complex challenges begin with simple steps.”

From Scientist to Industry Leader

Ekaterina didn’t set out to become a biomedical executive. Growing up in the Soviet Union, she was expected to become a teacher. But a single moment in kindergarten changed her trajectory. “I saw a picture of a DNA helix on a magazine cover,” she recalls. “Nobody around me could explain it, which deepened my curiosity.”

That spark led her to graduate studies in biochemistry and training in biomedical engineering management. Her academic journey took her across continents as she pursued the education to match her ambitions.

“Over the years, I rose to executive roles in the biomedical sector, guiding six biomedical products to commercialization – including FreeStyle Libre®, BioThrax®, Saphnelo®, and Kymriah®,” she says. A defining achievement was her leading contribution to the development of vaccines for Ebola Sudan and Marburg viruses – tools that helped frontline responders halt deadly outbreaks in Africa. The Sabin Vaccine Institute’s 70-day response was unprecedented and widely praised.

Her career achievement is leading global teams with P&L oversight of more than $250 million and serving as Principal Investigator on over $400 million in US government contracts. It is a career defined not by comfort, but by resolve.

A Commitment to Public Health – and to People

Public health has always been the foundation of her work. In the early 2010s at Emergent BioSolutions, Ekaterina led cross-agency collaborations with BARDA, CDC, FDA, and federal and industry partners to advance the first medical countermeasure licensed under the FDA Animal Rule.

“That experience taught me how powerful coordinated, mission-driven teams can be,” she says.

Her commitment extended beyond institutions. Mentorship became central to her mission. “Across early-stage incubators, I saw brilliant engineers and scientists stall not because they lack ideas, but because they lack seedfunding, prototype grounds, and early system validation opportunities,” she explains. Too many innovations “sit on shelves because their creators don’t know how to navigate those fragile first steps.”

A Natural Evolution: Building Climate-Resilient Medicine

Her work in global health crystallized a deeper realization: climate change is no longer a future threat – it’s a present medical crisis. Rising temperatures, extreme weather, and shifting disease patterns are already driving climate-linked morbidity. Communities need healthcare designed for this reality.

That urgency pushed Ekaterina toward entrepreneurship. She founded startups – built from the ground up and funded by NIH, NSF, and Maryland grants – to develop scalable, sustainable healthcare solutions.

Ekaterina believes that the Maryland innovation ecosystem can lead the emerging field of climate-adjustment medicine. “This surge of new morbidity requires climate medicine,” she says. “Maryland can build its own climate-resilient healthcare delivery. Investments in climate-adapted technologies can produce measurable impact and create licensable innovations. Preparation is a responsibility.”

A Blueprint for a Circular, Self-Sufficient Future

Ekaterina’s advocacy extends beyond Bio/Life Sciences. She believes Maryland’s resources are well-positioned to support sustainable innovation across sectors. She sees the state as fertile ground for a circular economy, in which resources are reused, repurposed, and reimagined.

“Self-reliance and self-sufficiency are top priorities for communities,” she notes. “For a state like Maryland, that means investing in technologies that solve problems with long-term vision.”

Consider agriculture. Maryland produces food surpluses yet still imports food to meet demand. By expanding recycling, composting, and productivity technologies, Ekaterina argues the state can strengthen local production and reduce vulnerabilities. With support from research powerhouses, the circular economy can become self-funding.

STEM and Environmental Restoration

Ekaterina’s commitment to innovation extends through volunteering. She spends weekends working at environmental restoration sites and coaching youth STEM teams, recently guiding her EcoWear middle school team to a Grand Prix win at Invent the Future 2025 at Kids Museum for their autonomous electricity-generating wearable.

Innovation as a Collective Act

If one belief defines Ekaterina’s work, it is unity: “We cannot innovate in isolation,” she says. “Collaboration – across borders, disciplines, generations – is the only way to build technologies with global impact and ethical responsibility.”

“We are the only species that draws national lines,” she adds. “Survival depends on our ability to leverage collective intelligence and develop a seventh sense: ecological awareness.”

“Start where you are. Use what you have. Do what you can.” For Ekaterina Vert-Wong, this is more than a phrase – it’s a blueprint for action. She believes the future belongs to those who lead with resourcefulness, scrappiness, imagination, and unity. And she sees those qualities embodied in Maryland – not just ready for the future, but positioned to lead it.

Other INNOVATE® Ecosystems